ArticleMagnetic resonance in medicine2026
MOdulation-Guided ENcoding (MOGEN) Scheme for Vessel-Encoded Arterial Spin Labeling.
Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeVessel-encoded arterial spin labeling (VEASL) enables simultaneous, non-contrast imaging of multiple vascular territories that is useful for differential diagnosis and treatment monitoring of cerebrovascular diseases. However, the existing encoding methods are signal-to-noise ratio (SNR) inefficient.
methodsWe developed a MOdulation-Guided ENcoding (MOGEN) scheme that directly exploits the inversion spatial modulation profile to obtain SNR-efficient encoding matrix. Simulations, phantom tests, and healthy volunteer scans were performed to demonstrate its feasibility in multiple application scenarios.
resultsSimulation studies demonstrated that MOGEN achieves significantly higher theoretical SNR efficiency than previous methods for both four- and six-artery configurations. In healthy volunteers, MOGEN improved in vivo SNR by approximately 15% and provided more robust vessel decoding, particularly when the spatial modulation deviated from a cosine profile. In patients with Moyamoya disease, MOGEN enabled reliable visualization of collateral pathways even when scan time was reduced to ˜5 min for six arteries. Furthermore, by considering vessel size with multi-voxel vessel representation, MOGEN enhanced single-artery selectivity in vessel-encoded angiography. We also demonstrated that a straightforward approach of off-resonance correction for VEASL at ultra-high field was feasible by using MOGEN.
conclusionMOGEN offered several benefits for VEASL, including high SNR efficiency, flexible spatial modulation and PCASL parameters selection, vessel size consideration, and straightforward off-resonance correction, thereby substantially improving robustness and usability of VEASL across various applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.